Anti-CTLA-4 immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-CTLA-4 immunotherapy, covering 2025-01-15 to 2025-01-15. Get the full timeline:
Most recent: Clinical Trial Update: Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours [Phase 1, Phase 2]